The obsessive-compulsive disorder drugs market was valued at USD 755.14 Million in 2025 and is expected to grow at a CAGR of 9.70%, reaching USD 1905.87 Million by 2035. The market growth is fueled by rising awareness of mental health disorders and the availability of advanced pharmacological treatments.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
9.7%
Value in USD Million
2026-2035
*this image is indicative*
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global obsessive-compulsive disorder drugs market is being driven by the rising investment in R&D and health care sector, the rapid development in the OCD treatment procedures, and the growing demand for off-level drugs and therapies.
Obsessive-compulsive disorder (OCD) is a medical condition characterised by unreasonable thoughts and obsessions or fears, which leads to compulsive behaviour in an individual. Antidepressants are often the first medications prescribed to treat OCD. The global obsessive-compulsive disorder drugs market can be divided on the basis of segments like products and regions.
Breakup by Product
Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The development of new drugs to treat the obsessive-compulsive disorder is one of the major factors driving the growth of the industry globally. With rising consumer awareness, the demand for drugs with enhanced bioavailability, safety, and dosage parameters has increased, leading manufacturers to focus on the R&D of new OCD drugs. Thus, the launch of these products is expected to aid the growth of the obsessive-compulsive disorder drugs industry over the forecast period. Further, the growing acceptance of off-label drugs in combination with the approved therapies is providing a boost to the industry.
The SSRI segment, among other product types, dominated the industry in 2020, owing to the presence of several SSRIs including fluoxetine, fluvoxamine, paroxetine, and others, coupled with their fewer side effects in comparison to other drug types. Further, North America accounted for the largest share in the industry in 2020 due to the rising prevalence of obsessive-compulsive disorder and increased government initiatives in the region to combat this condition. The region is expected to dominate the obsessive-compulsive disorder drugs market in the forecast period as well.
The report presents a detailed analysis of the following key players in the global obsessive-compulsive disorder drugs industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global obsessive-compulsive disorder drugs market is further likely to grow at a CAGR of 9.70% in the forecast period of 2026 and 2035.
The major drivers of the industry include the rising investment in the R&D and health care industry, development of new drugs to treat the obsessive-compulsive disorder, rising consumer awareness, and increased government initiatives.
The rapid development in the OCD treatment procedures, and the growing demand for off-level drugs and therapies are the key factors driving industry growth globally.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The major products in the industry are SSRI and TCA, among others.
The key players in the industry are Eli Lilly and Company, GlaxoSmithKline Plc, Lupin, H. Lundbeck A/S, and Pfizer Inc., among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share